# Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy

> **NCT05274230** · NA · UNKNOWN · sponsor: **Apollo Neuroscience, Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Stress Disorders, Post-Traumatic

## Interventions

- **DEVICE:** Apollo Wearable

## Key facts

- **NCT ID:** NCT05274230
- **Lead sponsor:** Apollo Neuroscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-08
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05274230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05274230, "Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT05274230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*